Business Description
Onward Medical NV
ISIN : NL0015000HT4
Compare
Compare
Traded in other countries / regions
ONWD.Belgium63E.GermanyONWRF.USAONWDb.UK IPO Date
2021-10-21Description
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.76 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.46 | |||||
| Debt-to-EBITDA | -0.45 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 16.6 | |||||
| 3-Year EPS without NRI Growth Rate | 21.9 | |||||
| 3-Year FCF Growth Rate | 19 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.28 | |||||
| 9-Day RSI | 35.72 | |||||
| 14-Day RSI | 41.9 | |||||
| 6-1 Month Momentum % | 53.97 | |||||
| 12-1 Month Momentum % | 0.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.17 | |||||
| Quick Ratio | 6.17 | |||||
| Cash Ratio | 5.78 | |||||
| Days Payable | 55.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -72.3 | |||||
| Shareholder Yield % | -0.73 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -69.45 | |||||
| ROA % | -47.43 | |||||
| ROIC % | -258.56 | |||||
| ROC (Joel Greenblatt) % | -1669.69 | |||||
| ROCE % | -52.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.11 | |||||
| Price-to-Tangible-Book | 5.86 | |||||
| EV-to-EBIT | -4.2 | |||||
| EV-to-EBITDA | -4.27 | |||||
| EV-to-FCF | -4.42 | |||||
| Price-to-Net-Current-Asset-Value | 6.42 | |||||
| Price-to-Net-Cash | 7.44 | |||||
| Earnings Yield (Greenblatt) % | -23.85 | |||||
| FCF Yield % | -20.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Onward Medical NV Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.2 | ||
| Beta | 0 | ||
| Volatility % | 60.01 | ||
| 14-Day RSI | 41.9 | ||
| 14-Day ATR (€) | 0.372335 | ||
| 20-Day SMA (€) | 5.1895 | ||
| 12-1 Month Momentum % | 0.41 | ||
| 52-Week Range (€) | 1.85 - 6.58 | ||
| Shares Outstanding (Mil) | 34.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Onward Medical NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Onward Medical NV Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Onward Medical NV Frequently Asked Questions
What is Onward Medical NV(XBRU:ONWD)'s stock price today?
The current price of XBRU:ONWD is €4.69. The 52 week high of XBRU:ONWD is €6.58 and 52 week low is €1.85.
When is next earnings date of Onward Medical NV(XBRU:ONWD)?
The next earnings date of Onward Medical NV(XBRU:ONWD) is .
Does Onward Medical NV(XBRU:ONWD) pay dividends? If so, how much?
Onward Medical NV(XBRU:ONWD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers